Učitavanje...
Quantitative Interrogation of the Human Kinome Perturbed by Two BRAF Inhibitors
Oncogenic BRAF mutations contribute to the development of a number of cancers, and small-molecule BRAF inhibitors have been approved by the Food and Drug Administration (FDA) for anticancer therapy. In this study, we employed two targeted quantitative proteomics approaches for monitoring separately...
Spremljeno u:
| Izdano u: | J Proteome Res |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6939617/ https://ncbi.nlm.nih.gov/pubmed/30994353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.jproteome.9b00134 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|